🇺🇸 FDA
Patent

US 11236151

Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection

granted A61KA61K38/00A61P

Quick answer

US patent 11236151 (Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61P, A61P31/22